BlackRock’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.7K | Sell |
|
|||||
|
2025
Q1 | $153K | Sell |
|
|||||
|
2024
Q4 | $181K | Buy |
|
|||||
|
2024
Q3 | $123K | Buy |
|
|||||
|
2024
Q2 | $204K | Sell |
|
|||||
|
2024
Q1 | $2.2M | Sell |
|
|||||
|
2023
Q4 | $1.73M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Sell |
|
|||||
|
2023
Q2 | $1.36M | Buy |
|
|||||
|
2023
Q1 | $818K | Sell |
|
|||||
|
2022
Q4 | $2.3M | Sell |
|
|||||
|
2022
Q3 | $423K | Sell |
|
|||||
|
2022
Q2 | $459K | Sell |
|
|||||
|
2022
Q1 | $990K | Sell |
|
|||||
|
2021
Q4 | $1.26M | Sell |
|
|||||
|
2021
Q3 | $1.92M | Sell |
|
|||||
|
2021
Q2 | $2.06M | Sell |
|
|||||
|
2021
Q1 | $8.5M | Buy |
|
|||||
|
2020
Q4 | $9.84M | Sell |
|
|||||
|
2020
Q3 | $9.01M | Sell |
|
|||||
|
2020
Q2 | $11.2M | Buy |
|
|||||
|
2020
Q1 | $6.32M | Sell |
|
|||||
|
2019
Q4 | $15M | Sell |
|
|||||
|
2019
Q3 | $12.6M | Buy |
|
|||||
|
2019
Q2 | $34.1M | Sell |
|
|||||
|
2019
Q1 | $36M | Buy |
|
|||||
|
2018
Q4 | $26.9M | Sell |
|
|||||
|
2018
Q3 | $41.1M | Buy |
|
|||||
|
2018
Q2 | $45.2M | Buy |
|
|||||
|
2018
Q1 | $19.2M | Buy |
|
|||||
|
2017
Q4 | $16.7M | Buy |
|
|||||
|
2017
Q3 | $7.34M | Buy |
|
|||||
|
2017
Q2 | $5.41M | Sell |
|
|||||
|
2017
Q1 | $2.79M | Buy |
|
|||||
|
2016
Q4 | $3K | Hold |
|
|||||
|
2016
Q3 | $3K | Hold |
|
|||||
|
2016
Q2 | $3K | Buy |
|